Related Experiment Video
Updated: Aug 22, 2026
Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
[Experimental study of sensitivity to chemotherapeutic agents for human endometrial carcinoma cell line]
Xiu-gui Sheng1, Ling Tang, Da-peng Li
1Department of Gynecological Oncology, Shandong Cancer Hospital, Jinan 250117, China. jnsxg@hotmail.com
Objective:
To screen the sensitive chemotherapeutic agents to human endometrial carcinoma cell line-1 (HECCL-1) and study its mechanism.
Methods:
MTT method was used to examine the relative inhibition ratios (RIRs) of various concentrations of 18 chemotherapeutic agents to HECCL-1. Cell cycle, apoptosis and expression of MDR1 protein were detected by FCM.
Results:
Nine of the chemotherapeutic agents studied obviously inhibited the proliferative activity of HECCL-1 in a dose-dependent manner. The order of sensitivity was as follows: adriamycin (ADM), oxaliplatin (L-OHP), carboplatin (CBP), cisplatin (DDP), taxol (TAL), epirubicin (EPI), mitoxantrone (MIT), dactomycin (ACTD) and 5-fluorouracil (5-Fu). FCM showed these agents could significantly reduce the proportion of cells in G0-G1 phase, and increase the proportion of cells in S and G2-M phase (P < 0.05). Cell apoptosis was observed in 11 chemotherapeutic agents at their peak concentration. MDR expression was induced after using EPI, 5-Fu, hydroxycamptothecin (HCPT) and MIT.
Conclusion:
HECCL-1 is sensitive to a number of the chemotherapeutic agents studied. Induced apoptosis may be the major mechanism of drug sensitivity, and acquired drug-resistance may be the critical reason against continued administration.
Insights
Human endometrial carcinoma cells (HECCL-1) show sensitivity to several chemotherapeutic agents, with induced apoptosis being a key mechanism. Acquired drug resistance may limit treatment efficacy.
Area of Science:
- Oncology
- Cell Biology
- Pharmacology
Background:
- Endometrial carcinoma is a significant gynecological malignancy.
- Identifying effective chemotherapeutic agents is crucial for treatment.
- Understanding drug sensitivity mechanisms is vital for improving patient outcomes.
Purpose of the Study:
- To screen chemotherapeutic agents for sensitivity against the human endometrial carcinoma cell line-1 (HECCL-1).
- To investigate the underlying mechanisms of drug sensitivity and resistance in HECCL-1.
Main Methods:
- Utilized the MTT assay to determine relative inhibition ratios of 18 chemotherapeutic agents.
- Employed flow cytometry (FCM) to analyze cell cycle, apoptosis, and MDR1 protein expression.
Main Results:
- Nine agents demonstrated significant, dose-dependent inhibition of HECCL-1 proliferation.
- Key sensitive agents included adriamycin, oxaliplatin, and carboplatin.
- Chemotherapy induced cell cycle arrest, increased apoptosis, and in some cases, MDR1 expression.
Conclusions:
- HECCL-1 exhibits sensitivity to multiple chemotherapeutic agents.
- Induced apoptosis appears to be the primary mechanism of drug sensitivity.
- Acquired drug resistance presents a critical challenge for sustained treatment effectiveness.
